2009Journal of psychiatryRequires access

Changes of the blood glucose,body weight and lipid levels in senile dementia treated with quetiapine or risperidone

Weihong Hu

Open publisher page 0 citations

Abstract

Objective To assess the effects of quetiapine and risperidone on the blood glucose ,body weight and lipid levels in elderly patients with dementia.Methods A total of 60 patients with senile dementia were randomly divided into quetiapine group and risperidone group.Planed assessments included blood glucose,total cholestrol (TC),triglycerides (TG),high density lipoprotein-cholesterol(HDL),low density lipoprotein-cholesterol (LDL) and the body weight,which were collected at baseline ,the end of 4th and 8th week after treatment.Results After 8-week treatment,the levels of body weight and LDL were significanlty higher and the levels of HDL were lower than those before treatment in quetiapine group (P 0.05). Quetiapine group showed significantly larger changes of body weight and LDL at the end of the treatment than risperidone group (P 0.05).Conclusion Quetiapine has more effects on the body weight and lipid levels than risperidone in patients with senile dementia.

About this research paper

What this paper is about

Objective To assess the effects of quetiapine and risperidone on the blood glucose ,body weight and lipid levels in elderly patients with dementia.Methods A total of 60 patients with senile dementia were randomly divided into quetiapine group and risperidone group.Planed assessments included blood glucose,total cholestrol (TC),triglycerides (TG),high density lipoprotein-cholesterol(HDL),low density lipoprotein-cholesterol (LDL) and the body weight,which were collected at baseline ,the end of 4th and 8th week after treatment.Results After 8-week treatment,the levels of body weight and LDL were significanlty higher and the levels of HDL were lower than those before treatment in quetiapine group (P 0.05). Quetiapine group showed significantly larger changes of body weight and LDL at the end of the treatment than risperidone group (P 0.05).Conclusion Quetiapine has more effects on the body weight and lipid levels than risperidone in patients with senile dementia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the effects of quetiapine and risperidone on the blood glucose ,body weight and lipid levels in elderly patients with dementia.Methods A total of 60 patients with senile dementia were randomly divided into quetiapine group and risperidone group.Planed assessments included blood glucose,total cholestrol (TC),triglycerides (TG),high density lipoprotein-cholesterol(HDL),low density lipoprotein-cholesterol (LDL) and the body weight,which were collected at baseline ,the end of 4th and 8th week after treatment.Results After 8-week treatment,the levels of body weight and LDL were significanlty higher and the levels of HDL were lower than those before treatment in quetiapine group (P 0.05). Quetiapine group showed significantly larger changes of body weight and LDL at the end of the treatment than risperidone group (P 0.05).Conclusion Quetiapine has more effects on the body weight and lipid levels than risperidone in patients with senile dementia.

Key concepts: Quetiapine, Risperidone, Blood lipids, Internal medicine, Endocrinology, Dementia, Medicine, Senile dementia

Related papers

Back to paper searchBrowse research topicsOriginal source
Changes of the blood glucose,body weight and lipid levels in senile dementia treated with quetiapine or risperidone — Research Paper | ScholarLens